Explore / Peer-reviewed article
Peer-reviewed article

Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.

Cao C, Barros-Álvarez X, Zhang SiD, Kim K, Dämgen MA, Panova O, Suomivuori CMiD, Fay JF, Zhong X, Krumm BE, Gumpper RH, Seven AB, Robertson MJ, Krogan NJ, Hüttenhain RiD, Nichols DE, Dror ROiD, Skiniotis GiD, Roth BL

NeuronSep 9, 2022United States169 citationsDOI: 10.1016/j.neuron.2022.08.006

Abstract

Serotonin (5-hydroxytryptamine [5-HT]) 5-HT2-family receptors represent essential targets for lysergic acid diethylamide (LSD) and all other psychedelic drugs. Although the primary psychedelic drug effects are mediated by the 5-HT<sub>2A</sub> serotonin receptor (HTR2A), the 5-HT<sub>2B</sub> serotonin receptor (HTR2B) has been used as a model receptor to study the activation mechanisms of psychedelic drugs due to its high expression and similarity to HTR2A. In this study, we determined the cryo-EM structures of LSD-bound HTR2B in the transducer-free, Gq-protein-coupled, and β-arrestin-1-coupled states. These structures provide distinct signaling snapshots of LSD's action, ranging from the transducer-free, partially active state to the transducer-coupled, fully active states. Insights from this study will both provide comprehensive molecular insights into the signaling mechanisms of the prototypical psychedelic LSD and accelerate the discovery of novel psychedelic drugs.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

LSD

Keywords

Gq proteinsignaling transductionStructural BiologyFunctional SelectivityPsychedelicΒ-arrestin-1Htr2b

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.